Cognitive enhancement following acute losartan in normotensive young adults

Psychopharmacology

Volumn 217, Issue 1, 2011, Pages 51-60

  Mechaeil, Rasha ^a   Gard, Paul ^b   Jackson, Anne ^a   Rusted, Jennifer ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Ageing; Angiotensin; Angiotensin receptor antagonists; Antihypertensive; Cognition; Losartan; Scopolamine

Indexed keywords

LOSARTAN; LOSARTAN POTASSIUM; PLACEBO; QWELLS; SCOPOLAMINE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; APTITUDE TEST; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG DOSE COMPARISON; DRUG MECHANISM; EPISODIC MEMORY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY; MONOTHERAPY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TASK PERFORMANCE; UNIVERSITY STUDENT;

ADOLESCENT; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; COGNITION; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOSARTAN; MALE; MEMORY, EPISODIC; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; SCOPOLAMINE HYDROBROMIDE; YOUNG ADULT;

EID: 82955198431     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2257-9     Document Type: Article

References (64)

1. Albiston AL, Morton CJ, Ng HL, Pham V, Yeatman HR, Holly R, Ye S, Fernando RN, De Bundel D, Ascher DB, Mendelsohn FAO, Parker MW, Chai SY (2008) Identification and characterization of a new cognitive enhancer based on inhibition of insulinregulated aminopeptidase. FASEB J 22:4209-4217
2. Barker A, Jones R, Prior J, Wesnes K (1998) Scopolamine-induced cognitive impairment as a predictor of cognitive decline in healthy elderly volunteers: a 6-year follow-up. Int J Geriatr Psychiatry 13(4):244-247 (Pubitemid 28192678)
3. Barnes NM, Champaneria S, Costall B, Kelly ME, Murphy DA, Naylor RJ (1990) Cognitive enhancing actions of dup 753 detected in a mouse habituation paradigm. Neuroreport 1(3- 4):239-242
4. Beatty WW, Butters N, Janowsky DS (1986) Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia. Behav Neural Biol 45(2):196-211 (Pubitemid 16164035)
5. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Psychol 47:211-218
6. Bonini JS, Bevilaqua LR, Zinn CG, Kerr DS, Medina JH, Izquierdo I, et al (2006) Angiotensin ii disrupts inhibitory avoidance memory retrieval. Horm Behav 50(2):308-313 (Pubitemid 44041349)
7. Brandimonte MA, Ferrante D, Feresin C, Delbello R (2001) Dissociating prospective memory from vigilance processes. Psychologica 22:97-113
8. Braszko JJ (2002) At(2) but not at(1) receptor antagonism abolishes angiotensin ii increase of the acquisition of conditioned avoidance responses in rats. Behav Brain Res 131(1-2):79-86 (Pubitemid 34143158)
9. Braszko JJ, Kulakowska A, Winnicka MM (2003) Effects of angiotensin ii and its receptor antagonists on motor activity and anxiety in rats. J Physiol Pharmacol 54(2):271-281 (Pubitemid 36781480)
10. Braszko JJ, Kupryszewski G, Witczuk B, Wisniewski K (1988) Angiotensin-II-(3-8)-hexapeptide affects motor-activity, performance of passive-avoidance and a conditioned avoidanceresponse in rats. Neuroscience 27:777-783 (Pubitemid 19025386)
11. Broks P, Preston GC, Traub M, Poppleton P, Ward C, Stahl SM (1988) Modelling dementia: effects of scopolamine on memory and attention. Neuropsychologia 26(5):685-700
12. Broocks A, Little JT, Martin A, Minichiello MD, Dubbert B, Mack C et al (1998) The influence of ondansetron and mchlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls. Biol Psychiatry 43(6):408-416 (Pubitemid 28172384)
13. Caine ED, Weingartner H, Ludlow CL, Cudahy EA, Wehry S (1981) Qualitative analysis of scopolamine-induced amnesia. Psychopharmacology (Berl) 74(1):74-80 (Pubitemid 11126464)
14. Curran HV, Schifano F, Lader M (1991) Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology (Berl) 103(1):83-90
15. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U et al (2002) Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (life): A randomised trial against atenolol. Lancet 359 (9311): 995-1003 (Pubitemid 34286536)
16. Ebert U, Siepmann M, Oertel R, Wesnes KA, Kirch W (1998) Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration. J Clin Pharmacol 38(8):720-726 (Pubitemid 28388222)
17. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR (1993) Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study. Am J Epidemiol 138 (6):353-364 (Pubitemid 23289288)
18. Ellis J, Kvavilashvili L (2000) Prospective memory in 2000: Past, present and future directions. Applied Cognitive Psychology 14: S1-S9
19. Ellis JR, Ellis KA, Bartholomeusz CF, Harrison BJ, Wesnes KA, Erskine FF et al (2006) Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int J Neuropsychopharmacol 9(2):175-189 (Pubitemid 43255831)
20. Flicker C, Serby M, Ferris SH (1990) Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacology (Berl) 100(2):243-250 (Pubitemid 20038570)
21. Fogari R, Mugellini A, Zoppi A, Derosa G, Pasotti C, Fogari E et al (2003) Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens 17(11):781-785 (Pubitemid 37441435)
22. Fogari R, Mugellini A, Zoppi A, Marasi G, Pasotti C, Poletti L et al (2004) Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur J Clin Pharmacol 59(12):863-868 (Pubitemid 38333676)
23. Fogari R, Mugellini A, Zoppi A, Lazzari P, Destro M, Rinaldi A et al (2006) Effect of telmisartan/hydrochlorothiazide vs lisinopril/ hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. J Hum Hypertens 20(3):177-185
24. Gard PR (2002) The role of angiotensin II in cognition and behaviour. Eur J Pharmacol 438:1-14 (Pubitemid 34242913)
25. Gard PR (2008) Cognitive-enhancing effects of angiotensin IV. BMC Neurosci 9(Suppl 2):S15 Gard P (2010) Non-adherence to antihypertensive medication and impaired cognition: which comes first? Int J Pharm Pract 8 (5):252-259
26. Ghoneim MM, Mewaldt SP, Thatcher JW (1975) The effect of diazepam and fentanyl on mental, psychomotor and electroencephalographic functions and their rate of recovery. Psychopharmacologia 44(1):61-66
27. Hanon F, Berrou J, Negre-Pages L, Goch JH, Nadhazi Z, Petrella R, Sedefdjian A et al (2008) Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the observational study on cognitive function and systolic blood pressure reduction open-label study. J Hypertens 26(8):1642-1650
28. Henry JD, MacLeod MS, Phillips LH, Crawford JR (2004) A metaanalytic review of prospective memory and aging. Psychol Aging 19(1):27-39 (Pubitemid 38338263)
29. Jönsson L, Gerth W, Fastbom J (2002) The potential economic consequences of cognitive improvement with losartan. Blood Press 11(1):46-52 (Pubitemid 34257356)
30. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al (2004). Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The value randomised trial. Lancet 363:2022-2031 (Pubitemid 38781102)
31. Kerr DS, Bevilaqua LR, Bonini JS, Rossato JI, Kohler CA, Medina JH et al (2005) Angiotensin ii blocks memory consolidation through an at2 receptor-dependent mechanism. Psychopharmacology (Berl) 179(3):529-535 (Pubitemid 40674753)
32. Kliegel M, Jäger T, Phillips L (2008)Adult age differences in event-based prospective memory: A meta-analysis on the role of focal versus nonfocal cues. Psychology and Aging 23(1):203-208 (Pubitemid 351626469)
33. Kliegel M, Martin M, McDaniel M, Einstein G (2004) Importance effects on performance in event-based prospective memory tasks. Memory 12(5):553-561. (Pubitemid 39236673)
34. Koller G, Satzger W, Adam M, Wagner M, Kathmann N, Soyka M et al (2003) Effects of scopolamine on matching to sample paradigm and related tests in human subjects. Neuropsychobiology 48(2):87-94 (Pubitemid 37176873)
35. Kopelman MD, Corn TH (1988) Cholinergic "blockade" as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome. Brain 111(Pt 5):1079-1110
36. Kulakowska A, Karwowska W, Wisniewski K, Braszko JJ (1996) Losartan influences behavioural effects of angiotensin ii in rats. Pharmacol Res 34(3-4):109-115 (Pubitemid 27075999)
37. Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek CI, Bjornsson TD (1995) Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite exp3174 in humans. Clin Pharmacol Ther 58(6):641-649 (Pubitemid 26018849)
38. Madden DJ, Blumenthal JA (1998) Interaction of hypertension and age in visual selective attention performance. Health Psychol 17 (1):76-83 (Pubitemid 28269773)
39. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL et al (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The charm-added trial. Lancet 362:767-771 (Pubitemid 37093916)
40. Mazzolai L, Maillard M, Rossat J, Nussberger J, Brunner H, Burnier M (1999) Angiotensin II receptor blockade in normotensive subjects: a direct comparison of three at AT1 receptor antagonists. Hypertension 33(3):850-855 (Pubitemid 29140445)
41. Mogi M, Li JM, Tsukuda K, Iwanami J, Min LJ, Sakata A, et al (2008) Telmisartan prevented cognitive decline partly due to ppar-gamma activation. Biochem Biophys Res Commun 375(3):446-449
42. Nelson HE (1982) National Adult Reading Test (NART): test manual. NFER-Nelson, Windsor Nicholson AN, Roberts DP, Stone BM, Turner C (2001) Antihypertensive therapy in critical occupations: studies with an angiotensin II antagonist. Aviat Space Environ Med 72(12):1096-1101
43. Nuotto E (1983) Psychomotor, physiological and cognitive effects of scopolamine and ephedrine in healthy man. Eur J Clin Pharmacol 24(5):603-609 (Pubitemid 13092236)
44. Ohtawa M, Takayama F, Saitoh K, Yoshinaga T, Nakashima M (1993) Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans. Br J Clin Pharmacol 35(3):290-297 (Pubitemid 23074055)
45. Pompéia S, Rusted JM, Curran HV (2001) Verbal fluency facilitated by the cholinergic blocker, scopolamine. Hum Psychopharmacol 17:51-59 (Pubitemid 34130354)
46. Putcha L, Cintron NM, Tsui J, Vanderploeg JM, Kramer WG (1989) Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. Pharm Res 6(6):481-485 (Pubitemid 19182184)
47. Rey A (1941) L"examen psychologique dans les cas d"encephalopathie traumatique. Archives de Psychologie 28(112):112-164
48. Rusted JM (1988) Dissociative effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology (Berl) 96(4):487-492 (Pubitemid 19002225)
49. Rusted JM, Warburton DM (1988) The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology (Berl) 96(2):145-152
50. Safer DJ, Allen RP (1971) The central effects of scopolamine in man. Biol Psychiatry 3(4):347-355
51. Saxby BK, Harrington F, Wesnes KA, McKeith IG, Ford GA (2008) Candesartan and cognitive decline in older patients with hypertension. Neurology 70:1858-1866 (Pubitemid 351653953)
52. Shepherd J, Bill DJ, Dourish CT, Grewal SS, McLenachan A, Stanhope KJ (1996) Effects of the selective angiotensin ii receptor antagonists losartan and pd123177 in animal models of anxiety and memory. Psychopharmacology (Berl) 126 (3):206-218 (Pubitemid 26252757)
53. Skoog I (1997) The relationship between blood pressure and dementia: a review. Biomed Pharmacother 51(9):367-375 (Pubitemid 27475312)
54. Srinivasan J, Jayadev S, Kumaran D, Ahamed KF, Suresh B, Ramanathan M (2005) Effect of losartan and enalapril on cognitive deficit caused by goldblatt induced hypertension. Indian J Exp Biol 43(3):241-246 (Pubitemid 40359129)
55. Spielberger CD, Gorsuch RL, Lushene RE (1970) STAI: manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo Alto, pp 23-49
56. Tariot PN, Patel SV, Cox C, Henderson RE (1996) Age-related decline in central cholinergic function demonstrated with scopolamine. Psychopharmacology (Berl) 125(1):50-56 (Pubitemid 26155364)
57. Tedesco MA, Ratti G, Mennella S, Manzo G, Grieco M, Rainone AC et al (1999) Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens 12(11):1130-1134
58. Tsukuda K, Mogi M, Li JM, Iwanami J, Min LJ, Sakata A, et al (2007) Amelioration of cognitive impairment in the type-2 diabetic mouse by the angiotensin ii type-1 receptor blocker candesartan. Hypertension 50(6):1099-1105 (Pubitemid 350172932)
59. Uttl B (2008) Transparent meta-analysis of prospective memory and aging. PLoS One 3:e1568 Vicario A, Martinez CD, Baretto D, Diaz Casale A, Nicolosi L (2005) Hypertension and cognitive decline: impact on executive function. J Clin Hypertens (Greenwich) 7(10):598-604
60. Vitiello B, Martin A, Hill J, Mack C, Molchan S, Martinez R et al (1997) Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans. Neuropsychopharmacology 16(1):15-24 (Pubitemid 27030992)
61. Waldstein SR, Manuck SB, Ryan CM, Muldoon MF (1991) Neuropsychological correlates of hypertension: review and methodologic considerations. Psychol Bull 110(3):451-468
62. Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, et al (2007) Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of alzheimer disease. J Clin Invest 117(11):3393-3402 (Pubitemid 350096995)
63. Wesnes K, Revell A (1984) The separate and combined effects of scopolamine and nicotine on human information processing. Psychopharmacology (Berl) 84(1):5-11 (Pubitemid 14032198)
64. Wesnes KA, Simpson P, Kidd A (1988) An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg s.c. Hum Psychopharmacol 3:27-41